FitLife Brands (FTLF) Competitors $13.40 +0.20 (+1.55%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. TYRA, TSHA, OPT, BCYC, KURA, SEPN, ABVX, MAZE, VALN, and BCAXShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Tyra Biosciences (TYRA), Taysha Gene Therapies (TSHA), Opthea (OPT), Bicycle Therapeutics (BCYC), Kura Oncology (KURA), Septerna (SEPN), Abivax (ABVX), Maze Therapeutics (MAZE), Valneva (VALN), and Bicara Therapeutics (BCAX). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Its Competitors Tyra Biosciences Taysha Gene Therapies Opthea Bicycle Therapeutics Kura Oncology Septerna Abivax Maze Therapeutics Valneva Bicara Therapeutics FitLife Brands (NASDAQ:FTLF) and Tyra Biosciences (NASDAQ:TYRA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership. Do analysts recommend FTLF or TYRA? FitLife Brands presently has a consensus target price of $20.50, indicating a potential upside of 53.05%. Tyra Biosciences has a consensus target price of $30.83, indicating a potential upside of 181.48%. Given Tyra Biosciences' higher possible upside, analysts clearly believe Tyra Biosciences is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is FTLF or TYRA more profitable? FitLife Brands has a net margin of 13.85% compared to Tyra Biosciences' net margin of 0.00%. FitLife Brands' return on equity of 25.59% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets FitLife Brands13.85% 25.59% 15.26% Tyra Biosciences N/A -26.90%-25.54% Do institutionals & insiders hold more shares of FTLF or TYRA? 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 84.1% of Tyra Biosciences shares are held by institutional investors. 61.4% of FitLife Brands shares are held by company insiders. Comparatively, 15.2% of Tyra Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher valuation & earnings, FTLF or TYRA? FitLife Brands has higher revenue and earnings than Tyra Biosciences. Tyra Biosciences is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFitLife Brands$64.47M1.95$8.98M$0.8415.95Tyra BiosciencesN/AN/A-$86.48M-$1.63-6.72 Does the media prefer FTLF or TYRA? In the previous week, Tyra Biosciences had 2 more articles in the media than FitLife Brands. MarketBeat recorded 3 mentions for Tyra Biosciences and 1 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.93 beat Tyra Biosciences' score of 0.66 indicating that FitLife Brands is being referred to more favorably in the media. Company Overall Sentiment FitLife Brands Positive Tyra Biosciences Positive Which has more volatility and risk, FTLF or TYRA? FitLife Brands has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. SummaryFitLife Brands beats Tyra Biosciences on 11 of the 16 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.46M$10.28B$5.51B$9.31BDividend YieldN/A2.06%4.25%4.09%P/E Ratio15.7816.9728.1819.72Price / Sales1.9529.19439.19110.06Price / Cash13.0222.2335.5357.53Price / Book3.413.598.235.67Net Income$8.98M$233.40M$3.23B$257.51M7 Day Performance1.55%-3.84%-0.61%-0.16%1 Month Performance-1.51%3.36%6.63%9.89%1 Year Performance-15.22%-18.22%27.07%15.08% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.0613 of 5 stars$13.39+1.5%$20.50+53.1%-21.0%$124.46M$64.47M15.7820TYRATyra Biosciences3.1182 of 5 stars$9.61-3.9%$30.83+220.8%-49.3%$530.90MN/A-5.9020TSHATaysha Gene Therapies4.0188 of 5 stars$2.34-4.5%$8.20+250.4%+3.3%$525.92M$8.33M-6.88180News CoverageOPTOpthea0.3881 of 5 stars$3.41+7.2%$1.33-60.9%+60.1%$524.84M$120K0.008Gap UpBCYCBicycle Therapeutics3.7294 of 5 stars$7.17-3.5%$25.00+248.7%-66.8%$514.56M$35.28M-2.28240KURAKura Oncology4.5634 of 5 stars$5.68-3.1%$24.50+331.3%-72.5%$507.33M$53.88M-2.70130Positive NewsSEPNSepterna1.3992 of 5 stars$10.85-4.6%$26.75+146.5%N/A$506.63M$1.08M0.00N/AABVXAbivax2.2636 of 5 stars$7.95-0.1%$31.00+289.9%-26.5%$505.10MN/A0.0061News CoveragePositive NewsGap UpHigh Trading VolumeMAZEMaze TherapeuticsN/A$12.12+5.4%$25.67+111.8%N/A$503.67M$167.50M0.00121VALNValneva1.7962 of 5 stars$5.75-1.0%$15.50+169.6%-13.6%$494.40M$183.52M-4.83700BCAXBicara Therapeutics1.9886 of 5 stars$9.01-0.2%$31.86+253.6%N/A$492.46MN/A0.0032News Coverage Related Companies and Tools Related Companies Tyra Biosciences Competitors Taysha Gene Therapies Competitors Opthea Competitors Bicycle Therapeutics Competitors Kura Oncology Competitors Septerna Competitors Abivax Competitors Maze Therapeutics Competitors Valneva Competitors Bicara Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTLF Stock Alerts